Newborn screening for treatable genetic conditions: past, present and future

Susan Hiraki1, Nancy S Green

  • 1Mailman School of Public Health, Columbia University, 722 West 168 Street, New York, NY 10032, USA.

Insights

Newborn screening programs significantly reduce infant deaths from genetic conditions. Obstetricians play a crucial role in educating expectant parents about this vital public health initiative.

Area of Science:

  • Public Health
  • Genetics
  • Obstetrics

Background:

  • Newborn screening is a successful public health program.
  • It reduces infant morbidity and mortality from genetic disorders.
  • The program's expansion necessitates enhanced patient education.

Purpose of the Study:

  • To highlight the importance of obstetricians in prenatal education for newborn screening.
  • To emphasize the need for patient understanding of newborn screening benefits.

Main Methods:

  • Literature review on newborn screening and patient education.
  • Analysis of the obstetrician's role in public health initiatives.

Main Results:

  • Obstetricians are well-positioned to educate patients about newborn screening.
  • Prenatal education about newborn screening is desired by expectant parents.

Conclusions:

  • Obstetricians are vital in informing patients about newborn screening.
  • Effective patient education can improve engagement with public health programs.

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...